Video

DDNA19: Cardiac Complications in Liver Disease Patients


 

AT DIGESTIVE DISEASES: NEW ADVANCES

Vidyard Video

Dr. Marc Klapholz of Rutgers University, Newark, N.J., explains the latest developments in portopulmonary arterial hypertension, hepatopulmonary syndrome, and cirrhotic cardiomyopathy, as well as the emerging field and association between non-alcoholic fatty liver disease and cardiovascular disease.

Recommended Reading

Myeloperoxidase elevated in HCV-related liver cancer
Federal Practitioner
Black patients present as sicker, more likely to receive liver transplant
Federal Practitioner
HCV adapts to HIV coinfection
Federal Practitioner
HCV, HBV, and HIV associated with autoimmune kidney diseases
Federal Practitioner
Maintaining virologic response predicted long-term survival in HBV patients with decompensated cirrhosis
Federal Practitioner
Good news, bad news about HCV in kidney disease
Federal Practitioner
Hep C–infected livers are safe for transplant
Federal Practitioner
It’s time for universal HCV screening in the ED
Federal Practitioner
Women survive more often than men do when hospitalized with cirrhosis
Federal Practitioner
One-time, universal hepatitis C testing cost effective, researchers say
Federal Practitioner